Alessandro Beneduce
@ABeneduceMD
Interventional Cardiologist @SanRaffaeleMI Fellow @cliniquepasteur | #EAPCI Accreditation, Training and Certification Committee | FESC @escardio
#PCRLV 2024 is just around the corner! Be part of this year’s brand new simulation-based #learning program on #RedoTAVI Join us in London! 🇬🇧🤖❤️ @DrArifK @myriam_akodad Vinnie Bapat @David_Meier_ @ignamatsant @fra_giannini1 @nbuzzatti @dmylotte #TAVI #TAVR
The DECISION QFR Trial shows #QFR is a viable alternative to FFR for revascularization in multivessel disease, offering substantial agreement in treatment decisions and shorter procedure times. #EIJBestOf ow.ly/tsEy50WkVGv
Mitral valve replacement or repair and long-term risk of infective endocarditis. Read the results of an interesting Danish nationwide study #EHJ 👉 ow.ly/4wCR50WrMMV @RoccoMontone @ehj_ed
Just published: Retrograde Balloon-Induced Anterior Mitral Leaflet Laceration: The ROBIN Technique sciencedirect.com/science/articl… @PedroMDMSc @AhmadJabri8 @GKFram @g_giustinoMD @engelpedro @TiberioFrisoli
@CRT_meeting Boot Camp focusing on complications today with @esbrilakis @ronwaksman
“You don’t rise to the level of your complications, You fall to the level of your preparation.” Words of wisdom from our graduating 🇦🇺 fellow @DrPrimeroNg #compcourse2025 @crfheart
In this randomized trial, OAC did not outperform DAPT in preventing cerebral microembolism post-TAVI. DW-MRI findings suggest DAPT may lead to lower total embolic volume at 90 days. 🔗 ow.ly/J9b050Wn4tf #TAVI #StrokePrevention
Thanks for sharing @DFCapodanno I personally still don’t know what to propose post TAVI. Apart from those with clear indications for DAPT or NOAC, I tend to stay with aspirin alone 🤷🏾♂️ @PCRonline
In the randomized, open-label AUREA trial, an OAC strategy for 3 months post-TAVI did not show any benefit over an antiplatelet strategy in preventing cerebral microembolism in patients without an indication for OAC. Patients treated with DAPT showed a lower mean volume of brain…
⚡️ Conduction Disturbances after TTVR: the TRIPLACE Registry 🔎How often? 🔎When? 🔎Why? Read on @JACCJournals 🔗jacc.org/doi/full/10.10… @azeemlatib RishiPuri @npfam1 @modine_thomas @MonteHeart @MontefioreNYC @EinsteinMed #CardioED #MedEd
In the randomized, open-label AUREA trial, an OAC strategy for 3 months post-TAVI did not show any benefit over an antiplatelet strategy in preventing cerebral microembolism in patients without an indication for OAC. Patients treated with DAPT showed a lower mean volume of brain…
Want to strengthen your skills with an Advanced Course on Transseptal Puncture? Join a small-group, simulation-based workshop in: 🇧🇷 Rio de Janeiro, 9-10 September: pcronline.com/Courses/transs… 🇮🇹 Milan, 2-4 November: pcronline.com/Courses/transs… Strictly limited to 24 participants per…
Important finding on CT and fluoro showing 2nd TAV in Redo #TAVR were 100% underexpanded despite procedural optimization with pre and post dilatation. Time to rethink lifetime management strategy and consider #TAVR explant in low risk pts to avoid redo TAVR PPM ? @JACCJournals…
First study reporting valve frame expansion & geometry by MDCT and fluoroscopy of both index & second valve in patients undergoing redo-TAVR. Larger studies with longer follow-up are needed jacc.org/doi/10.1016/j.… #JACCINT #TAVR #NYValves2025
@crfheart #NYValves2025 #LBCT 2-yr Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study @GilbertTangMD 🔹No device-related deaths, disabling strokes, or reinterventions 🔹Improvements in stroke volume, CO, RV…
Day 2 at #NYValves2025 did not disappoint! 🎉Cutting-edge late-breaking science, live cases, and vibrant networking filled the halls. Swipe through these moments capturing the passion and progress driving our field forward! 🚀 #CardioX #CardioTwitter #CardioEd #CardioResearch…
Chimney stenting during redo-TAVI: risks and limitations. In an ex vivo study, stent distortion and underexpansion were frequent with SAPIEN 3 Ultra in failed supra-annular valves, often compromising future coronary access. ow.ly/xxFJ50WcKu9 #TAVI #ChimneyStenting…
What a kickoff to #NYValves2025! 🚀 From cutting-edge science to hands-on sessions, today was packed with innovation, education, and amazing connections. Here’s a glimpse of the excitement from Day 1! 🔥🫀 #CardioX #CardioTwitter #CardioEd #CardioResearch @jgranadacrf…
Welcome to #NYValves2025! 🎉 Drs. Juan Granada and Martin Leon kick off three powerful days of structural heart innovation, connection, and education in NYC. Let’s go! 🫀💥
🔥 Packed house this morning for the #NYValves2025 Late-Breakers!
New data on the JenaValve Trilogy System for #aorticregurgitation: In this multicentre registry, 24.1% of patients required a new PM post-#TAVI. Pre-existing AV block and RBBB predicted PPI, but no modifiable procedural risk factors were identified. #EAPCI ow.ly/7VmM50WcKnm
Celebrating continued progress: EuroIntervention’s Impact Factor reaches 9.5! This achievement reflects the journal’s growing influence in #InterventionalCardiology and the unwavering commitment of its authors, reviewers & editors. 👏Thank you for your continued trust and…
I am pleased to announce that the new Impact Factor of EuroIntervention is the highest in its 20-year history: 9.5. Ranked 16th out of 230 journals in the cardiovascular category (+5 positions versus the previous year). Thank you all — it’s an exciting rollercoaster.